Racura Oncology LtdASX: RAC

US FDA Orphan Drug Designation Awarded to RC220 Bisantrene

Jun 11, 2024 at 3:19 AM UTC · Issued by Racura Oncology Ltd

Race Oncology Ltd has released a press release.

View Attachment